OBJECTIVES: Twenty years ago our institution published an analysis of a cluster of failures associated with the arterial switch operation (ASO). The concept of 'near miss' was explored to detect warning signs of suboptimal performance. The aim of the current study was to review the parameters best suited to monitoring early ASO outcomes in the modern setting and re-examine the concept of near misses as failure equivalents.
INTRODUCTION
The early outcomes of the arterial switch operation (ASO) for patients born with transposition of the great arteries (TGAs) are a good example of the evolution of paediatric cardiac surgery over the past 40 years. After an initial learning phase, the results of ASO continued to improve [1] [2] [3] . At present, the 30-day survival rate for patients operated in 2012-13 in all UK paediatric cardiac units and reported by the National Institute for Cardiovascular Outcomes Research is 97.3% for simple TGA and 95.1% for patients with TGA and ventricular septal defect [4] . However, we recognize that ASO still poses challenges in clinical practice, and that 30-day mortality is a gross approximation of the quality of the results.
In this paper, we reapply the traditional cumulative sum (CUSUM) analysis techniques of monitoring of the results and revisit the concept of near misses as failure equivalents that we introduced 20 years ago. We hypothesize that with the current advances in pre-, peri-and postoperative care, the traditional 30-day measure might not best reflect the early outcomes of the current cohort of TGA patients. As the 90-day postoperative time window is currently explored in association with adult cardiac surgery [5] and paediatric intensive care [6] , we chose this time frame as a point of comparison to represent early outcomes.
METHODS
project was registered as a clinical audit/quality improvement project based on retrospective review with Great Ormond Street Hospital for Children NHS Foundation Trust and as such review by a Research Ethics Committee approval was waived.
The live status of each patient was traced according to their National Health Service (NHS) number and from their hospital records. Using the electronic database of the hospital and archived paper records as appropriate, we noted the patients' primary morphology, coronary anatomy as defined in the operation note, weight and age at surgery, operating surgeon, total cardiopulmonary bypass (CPB) time, cross-clamp time, intensive care unit (ICU) length of stay and whether CPB was re-established or extracorporeal membrane oxygenation (ECMO) required. As a surrogate for operational complexity, the patients who had long CPB time that was associated with early mortality were identified.
For the patients who died within the first year of the operation, we registered the date and cause of death (where available), and noted whether they died within the same hospital admission as the ASO. For reinterventions within 90 days, the date and type of operation or catheter procedure was recorded. Reintervention was defined as an additional procedure addressing the corrected lesion; thus, delayed chest closure or exploratory sternotomy was not classified as reintervention. The common closing date for data retrieval was December 2013.
For CUSUM analysis, all patients were assigned a consecutive sequence number in the chronological order of operation date. This study examines the outcome in the first year with particular emphasis over the first 90 days after surgery, as a more realistic period for performance monitoring.
Surgical technique
The current surgical technique at our institution has been described previously [7] [8] [9] . For completeness, some fundamental surgical steps are reiterated. The original aorta is transected high, and coronary transfer is undertaken, in most cases, using two smallish medial trap doors without any distortion of the new sinotubular junction. In cases with intramural coronary arteries, the intramural course is routinely unroofed.
In patients with transposition of great arteries with ventricular septal defect (TGA-VSD), the intracardiac repair is performed prior to the arterial switch. In cases of TGA with concomitant aortic arch repair, the coronary transfer is performed during the cooling for deep hypothermic circulatory arrest at 18°C, and the LeCompte manoeuvre facilitates the completion of aortic arch repair.
Variations to operative procedures within the study period
Phenoxybenzamine was routinely administered before the commencement of CPB until the early 1990s. Until 2005, a period of deep hypothermic circulatory arrest was used (at 18°C), and most patients only received a single dose of crystalloid cardioplegia.
Most notable current changes, implemented in Era 3, include the utilization of mild hypothermic (32-34°C) continuous bypass, multiple doses of blood cardioplegia, higher target haematocrit level (at least 30%), continuous filtration on CPB as well as postbypass ultrafiltration, tight control of oncotic pressure and the use of milrinone.
It is worth noting that all surgical and procedural changes occurred over transition periods of varying lengths. For example the CPB strategy slowly changed from deep hypothermic circulatory arrest to continuous bypass at mild hypothermia over the course of a few years. In our chronological analysis, it is not possible to pinpoint an exact moment when any particular change was implemented as routine.
In terms of surgeon experience in the time period of this large cohort of patients, the process of increasing specialization was introduced during Era 2, and was fully implemented in Era 3.
Use of extracorporeal membrane oxygenation ECMO has been offered as a rescue treatment for cardiopulmonary failure at our centre since 1992. In the context of ASO, ECMO was offered either where the baby had very poor cardiac function immediately after the operation (from the operating theatre) or after the child showed signs of severe deterioration refractory to conventional therapies in the ICU following surgery despite an apparently satisfactory surgical repair. In all cases, our protocol is to optimize conventional aspects of surgical and intensive care prior to commencing ECMO. However, on occasion, ECMO may be deployed as an emergency measure allowing for a period of stability for further evaluation and treatment of any possible residual lesions.
Near-miss indicators
The concept of near miss as introduced in a previous publication from our institution can vary across time. De Leval et al. [10] discussed the concept of a near-miss event, one more frequent than the outcome of primary interest (mortality in this case) but strongly associated with it. A near miss was thus defined as an event other than death that can be considered as a failure/adverse event, having connotations of rescue with or without injury. In that publication, the criterion chosen as having near-miss analogies was the need to reinstitute CPB after a trial of weaning. Other outcome measures reflecting significant postoperative morbidity were also reviewed, such as the need for postoperative peritoneal dialysis and aggressive inotropic support, but were rejected as near misses [11] .
In this study, we chose to explore three near-miss indicators and their applications to the arterial switch across the experience. The first one was re-establishing CPB as previously discussed in the cluster of failures report [10] , focusing on patients operated during Era 1. The second was the need for postoperative ECMO (technology that was available only in the surgical eras 2 and 3), that can be seen as the modern replacement for previously arbitrarily defined aggressive pharmacological therapy. The third was to try to identify a threshold for the duration of total CPB associated with mortality. The frequency of each potential near-miss indicator was recorded in each era, and the relation to 30-and 90-day mortality was assessed in a univariate manner with a χ 2 test.
Patient and operative characteristics
Patient and operative characteristics were recorded separately for all three eras. Differences between the eras were examined with cross-tabulation and the χ 2 test when the variable was categorical. The distribution of some continuous variables (like CPB time) was very skewed and so medians were compared across eras with nonparametric tests.
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Statistical analysis
Continuous data are presented mean ± standard deviation for normally distributed variables and median (interquartile range) otherwise. Categorical and binary data are presented as n (%). Comparisons across time eras using continuous data were performed using analysis of variance for normally distributed data and the Kruskal-Wallis test otherwise. For categorical or binary data, these comparisons were made using a χ 2 test or Fisher's exact test when appropriate.
The CUSUM analysis was prepared for 30-day deaths, 90-day deaths and in-hospital deaths based on the chronological sequence number allocated to each patient throughout the 30-year experience. To explore how the rate of mortality decreased over the experience, and to provide current mortality estimates, a logistic regression model was created using a sequence number as a predictor of 30-and 90-day mortality. Graphical analysis was then performed plotting the chronological sequence number versus 30-and 90-day mortality rates and numbers of deaths. Time periods during the study were separated into 10-year eras based on the distribution of changes in mortality rates over time from CUSUM analysis.
Hypothetical risk factors for early death were explored in univariable fashion with logistic regression. If the number of events in a category was <10 events per variable tested, then exact logistic regression was used to calculate 95% confidence intervals and P-values. To identify a threshold for the duration of total CPB associated with death, logistic regression was performed using this duration to predict 30-day mortality for the entire cohort and a threshold (>240 min) was chosen where specificity for predicting death was maximized.
SPSS version 21 (SPSS, Inc., Chicago, IL, USA) and STATA (StataCorp. 2012, Stata Statistical Software: Release 12, College Station, TX, USA) were used for all analyses. A two-sided P-value of 0.05 or less was considered statistically significant.
RESULTS
Completeness of data
We were able to determine the date of birth, date of operation, a date of death if applicable, gender, diagnosis, coronary anatomy and the date and type of first reintervention for all patients in the cohort until the date of censoring. Weight at surgery was recorded for 598 (99%) patients, CPB time for 591 (98%), cross-clamp time for 598 (99%) patients. Whether the patient required the reinstitution of CPB ('back to bypass') was determined for 594 (98%) of the patients, and the need for ECMO was known for everyone (100%). Of the 64 patients who died within 90 days of the operation, we were able to define recorded causes of death from patient notes, death summaries or death certificates for 56 (88%).
Patient and surgical demographics
The inherent characteristics of patients remained very similar throughout the experience as can be seen from (Table 1 ). There were no significant differences between gender (P = 0.77), morphology (P = 0.67), coronary anatomy (P = 0.42) or the median weight of patients undergoing surgery (P = 0.29) between the three eras. Across the three eras, the median CPB time (P = 0.001) and cross-clamp time (P = 0.001) decreased significantly and the shortening trend in median ICU stay displayed borderline statistical significance (P = 0.05).
Mortality
Mortality rates for each era are outlined in (Table 1) . For the entire study, 90% (64/71) of patients who died within the first year died within 90 days of ASO. The CUSUM method of sequential monitoring is applied to 30-day death, in-hospital death and 90-day death in (Fig. 1) . The number of patients dying within 30-90 days after surgery was higher during second and most recent eras, whereas the numbers of deaths within 30 days had reached a plateau by Era 3. In Eras 1 and 2, there were very few deaths occurring within the 30-to 90-day window. In other words, of all patients who died within 90 days of the operation, the proportion of those who died between 30 and 90 postoperative days (i.e. the extended early outcome monitoring period) was steadily increasing. Deaths between 30 and 90 days constituted 12% of early deaths in Era 1, 36% in Era 2 and 67% in Era 3.
Of the 18 patients who died after 30 days but before 90 days, 14 (78%) had been discharged from our hospital and 4 (22%) died with the same hospital episode. This was in contrast to those 30-day deaths where all but one (46/47, 98%) were in-hospital deaths. Figure 2 displays the decreasing probability of 30-day death by the chronological patient sequence number grouped in simple and complex TGA. Univariable risk factor analysis for early death is presented in Table 3 .
Causes of death
Causes of death for all eras are summarized in Table 2 .
Near misses
The analysis was limited to predicting 30-day mortality in Eras 1 and 2 since few deaths occurred within the 30-to 90-day window in these eras. During Eras 1 and 2, patient-related risk factors could be identified that were associated with 30-day mortality. However in Era 3, no patient-related risk factors could be identified which were associated with short-term mortality.
Re-establishing CPB was a significant risk factor in Era 1, but not so in Eras 2 and 3 after the introduction of ECMO. Interestingly, by Era 3, none of the patients who required re-establishing CPB died within 30 days and there was no association with 90-day mortality.
Prolonged CPB (>240 min) was significantly associated with mortality in all three eras. The 44 patients who fell in this nearmiss category had a diagnosis of transposition of great arteries with intact ventricular septum (TGA-IVS) (n = 20), TGA-VSD (n = 10), Taussig-Bing (n = 7) or Taussig-Bing with a concomitant arch anomaly (n = 7).
ECMO was the strongest predictor of mortality in Eras 2 and 3. In Era 3, ECMO was very strongly associated with death within 90 days.
The incidence of near misses (back to bypass, prolonged CPB and ECMO) is displayed in Table 1 . The proportion of patients requiring going back on CPB is lower in the Eras 2 and 3 (P < 0.001) and the proportion of patients with prolonged CPB times is reducing over time (P < 0.001). In the latest era 3, all 3 patients who died within 30 days received ECMO, and 7/12 (58%) who received ECMO in this era died within the first 90 postoperative days.
In the near-miss category, there were no further deaths between 90 days and 1 year in Era 1, two further deaths in Era 2 and one further death in Era 3, resulting in a 1-year mortality rate of the near-miss patients at 47% for Era 1, 71% for Era 2 and 67% for Era 3.
Reinterventions within 90 days
In Era 1, there were only two reinterventions that took place within the first 90 days after ASO. Both included a residual VSD closure, and one of the patients underwent a concomitant pulmonary artery reconstruction.
The early reinterventions in patients who died within 90 days of ASO are outlined in Table 2 . In the survivors of the whole cohort, we observed 13 surgical reinterventions within 90 days including residual VSD closure (n = 1), coarctation repair (n = 1), coronary reimplantation (n = 3), coronary artery bypass grafting (n = 2), mitral valve repair (n = 1), main pulmonary artery pseudo-aneurysm repair (n = 1), pulmonary artery banding (n = 1) and reconstruction of either the left (n = 2) or both (n = 1) branch pulmonary arteries. In the same surviving cohort, there were five early catheter reinterventions: balloon dilatation of either both (n = 3) or left (n = 1) pulmonary artery and stenting of the left pulmonary artery (n = 1).
DISCUSSION
We reviewed how best to track ASO early outcomes over time in our unit. Our data confirm that, over the last 30 years, early mortality after ASO has vastly decreased. However, in our experience, the proportion of early deaths that happened after 30 days but before 90 days has grown in the last 20 years, suggesting that the early hazard phase for the ASO operation has extended.
Monitoring only 30-day mortality under present circumstances can be superficially reassuring: the 30-day CUSUM plot is currently 
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virtually horizontal. However, the mortality before 90 days is declining at a slower rate. One interpretation is that we are rescuing more patients in the initial postoperative phase, without always leading to recovery and subsequent survival. This information should be acknowledged when quoting the operational risk to professionals or a family. An important proportion of the deaths between 30 and 90 days in our cohort occurred after initial discharge from hospital; this alerts us to the need to review and tighten our predischarge management and imaging plan and post-discharge protocols.
Near misses
The previous cluster of failures paper introduced the concept of a measure of near miss for within-institution monitoring. An ideal near-miss measure will be statistically associated with the primary outcome measure, have connotations of rescue and also be a clinically important variable in itself. The definition of a near miss may depend on the unit, but it must be reasonably prevalent to justify monitoring. We appreciate that re-establishing CPB or a prolonged CPB time (>240 min) are not ideal markers of modern near misses. In Era 1, however, in the absence of ECMO technology and suboptimal ECHO imaging, it is not unreasonable to assume that re-establishing bypass was often used as an urgent support measure. We do believe that if re-establishing CPB was to be further evolved as a near-miss marker, a clearer causality would have to be established. The research team would have to select only those cases where reinstituting CPB is used as a support measure for a failing circulation such as coronary revision, not for reasons such as air in the myocardium. Unfortunately, our data did not provide specific reasons for the second CPB run for all patients and, thus, we used it as a surrogate variable, acutely aware of its profile and limitations as a blunt tool. As a matter of fact, our analysis of results from recent eras did not support a second run of CPB as a near-miss marker in the more modern eras 2 and 3.
Similarly, a CPB time >240 min could be related to a complex switch involving VSD and arch reconstruction, and per se is not necessarily the cause of a near miss. The 44 patients who had a bypass time greater than 240 min were TGA-IVS (20), TGA-VSD (10), Taussig-Bing (7) and Taussig-Bing with Arch (7). On the other hand, there were 13 patients who had TGA-VSD with a concomitant arch repair, and the mean CPB time for these patients was 151 min. In our opinion, the extremely extended CPB time of 240 min can represent some sort of an operational challenge including a second run of bypass, as we do not commonly see such a long pump run even in our most complex patients in our current eras.
ECMO, however, not only fulfilled these first two criteria mentioned to describe near misses in our cohort, is also important in its own right as it has significant implications for potential morbidity, mortality and resources.
While understanding that the definition of a near miss may be negotiable, monitoring not only the patients who died, but those who 'came close', can enhance a unit's internal assessment of performance and perhaps alert a team to an unfavourable trend prior to changes in mortality. Also, the addition of near-miss outcomes provides more adverse events to risk models than deaths alone, as early mortality is fortunately becoming very rare in many paediatric cardiac operations.
Limitations of 30-day and in-hospital outcome measure
The validity of 30-day mortality or operative mortality as an outcome measure has been discussed in other settings of cardiac surgery. In a cohort study in adult patients undergoing coronary artery bypass surgery, it was observed that, despite the increasing risk profile in the surgical patient population, the immediate postoperative outcome has steadily been improving in the modern surgical era; however, an important trend for poorer late survival exists [5] . In another example, 43 hospitals performing coronary artery bypass grafting differed significantly in assessment of outcomes depending on whether 30-day mortality was used, or whether also deaths occurring up to 6 months after surgery that were judged to be a direct result of a perioperative complication were included [12] .
Recent data from the European Association for Cardiothoracic Surgery Congenital Database further suggest that 30-day mortality also has important limitations within the remit of modern paediatric cardiac surgery, as in-hospital mortality was significantly higher than 30-day mortality (10.7 vs 9.1%, respectively) [13] . We also appreciate that both 'near' real-time monitoring of early outcomes of congenital heart surgery in individual institutions [14] and the interinstitutional benchmarking of outcomes [1] have advanced enormously in the past decades. The traditional 30-day measure might not best reflect the early outcomes of the current patients in keeping with the recent advances in pre-, peri-and postoperative care.
In our hospital, the impact of ECMO on length of hospital stays after cardiac surgery has already been recognized, and in fact when reporting outcomes of the ECMO cohort, 90 days is used routinely instead of the traditional 30 days [6] .
Limitations of 90-day outcome measure
An extended window of monitoring can be challenging in the multicentre setting. The availability of information about live status at 90 days is not as straightforward everywhere as within the remit of national tracking using the NHS number in the UK. When the 90-day time horizon was explored within adult cardiac surgery in association with the development of the EuroSCORE II risk model [15] , 90-day survival status could only be achieved for 43% of patients.
Alternatives to 30-or 90-day mortality have been used as outcome measures; in-hospital or discharge mortality as a concept can be appealing. However, policy differences between programs result in unjust comparisons, as some institutions tend to discharge patients early to further hospital care in a secondary institution.
Risk factors for early death
The risk factor analysis in this report needs to be interpreted with some caution. In Era 1, the initial learning era, there was significant early mortality which correlated strongly with the risk factors of complexity that we do not recognize today. However, univariate risk factors such as intramural coronary course did not reach statistical significance in the multivariate model. The indicated near miss for that era, re-establishing bypass, seemed to best indicate the patients at a heightened risk for early death. Long ICU stay was in fact a 'protective' factor, given that most patients died in the immediate days following surgery.
In Era 2, the complex anatomy still increased operative risk, and we saw that course of postoperative ECMO was strongly associated with early death. The latter also applied to the most recent Era 3. However, in modern surgery, repair of ventricular septal defect or aortic arch anomalies are no longer considered to add a significant layer of complexity to the surgery itself and no heightened risk could be identified in our cohort during the last 10 years (Era 3).
Early reinterventions
Dramatically falling early mortality, while the patient population appears to remain of similar complexity, can be seen to result in a slightly increasing rate of early reinterventions. The current understanding of the underlying disease and immediate postoperative physiology has led to a very proactive approach, where arising problems can be anticipated, recognized and tackled as early as possible. It could be argued that some of the patients requiring an early reintervention in the latest era would have succumbed in the earlier eras, re-enforcing the understanding that the complexity of patients is similar but our means to bring them through the early postoperative phase have improved.
Given the high mortality associated with ECMO, it could even be considered as grounds for a transplantation listing. However, due to the dire donor organ shortage in the UK, the primary treatment objective for these patients is still a very tight conservative management coupled with any necessary interventions to optimize the circulation. Much of the early mortality following ECMO support appears to be related to ischaemia and one could consider that, in some cases, the reimplantation of the coronary arteries might be indicated before the patient is placed on ECMO in the operating theatre. However, considerable surgical experience as well as the skill and confidence to identify subtle coronary mal-alignment are required to take down a complex repair for a possible successful coronary reimplantation.
Nowadays, the surgical standard is the pursuit of a perfect operation. This is a prerequisite for surgical excellence, but unexpected adverse events can always occur. With the experience accumulated in the past decades, the care teams today must be able to deal with the unexpected and pave the way for optimal recovery. With longer term research, a reduction in overall mortality could be achieved by further lowering the risk in the 30-90 days postsurgical period and by preventing a near miss from becoming a 'direct hit'.
CONCLUSION
Despite excellent early results of ASO, emerging data suggest that the early hazard phase of the operation has been extended to a 90-day window. This is partly due to the evolution of intensive care and extracorporeal life support.
We suggest that, if similar audits of other neonatal or infant cardiac conditions show comparable patterns, 90-day outcomes may be more fruitfully monitored than the traditional 30-day model.
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